English

Aptalis Pharma Inc

EDGAR

Report (type unavailable) · filed 2012-04-27

15 filing records in this dataset, filed from 2008-12-22 to 2012-04-27. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

142 million USD

2011-09-30 · USD

Exact inputs and evidence

Revenue: 470384000 USD Source
Revenue: 328453000 USD Source

Operating margin

-3.98%

2011-09-30 · %

Exact inputs and evidence

Operating Income: -66402000 USD Source
Operating Income: -60755000 USD Source
Revenue: 470384000 USD Source
Revenue: 328453000 USD Source

Operating cash flow

14.6 million USD

2011-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -49010000 USD Source
Operating Cash Flow: -63575000 USD Source

Free cash flow

12.5 million USD

2011-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -49010000 USD Source
Operating Cash Flow: -63575000 USD Source
Capital Expenditure: 7408000 USD Source
Capital Expenditure: 5315000 USD Source

Cash and cash equivalents: 127 million USD 2011-09-30 Source
Exact value

126509000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-188 million USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Net income: 1446000 USD · 2010-10-01 – 2010-12-31 Source
Net income: -71669000 USD · 2011-01-01 – 2011-03-31 Source
Net income: -80790000 USD · 2011-04-01 – 2011-06-30 Source
Net income: -187884000 USD · 2010-10-01 – 2011-09-30 Source
Net income: -151013000 USD · 2010-10-01 – 2011-06-30 Source

Operating cash flow

-49 million USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Operating cash flow: 3696000 USD · 2010-10-01 – 2010-12-31 Source
Operating cash flow: -44918000 USD · 2011-01-01 – 2011-03-31 Source
Operating cash flow: -63575000 USD · 2010-10-01 – 2011-06-30 Source
Operating cash flow: -41222000 USD · 2010-10-01 – 2011-03-31 Source
Operating cash flow: -49010000 USD · 2010-10-01 – 2011-09-30 Source
Operating cash flow: -63575000 USD · 2010-10-01 – 2011-06-30 Source

Capital expenditure

7.41 million USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Capital expenditure: 1135000 USD · 2010-10-01 – 2010-12-31 Source
Capital expenditure: 2371000 USD · 2011-01-01 – 2011-03-31 Source
Capital expenditure: 5315000 USD · 2010-10-01 – 2011-06-30 Source
Capital expenditure: 3506000 USD · 2010-10-01 – 2011-03-31 Source
Capital expenditure: 7408000 USD · 2010-10-01 – 2011-09-30 Source
Capital expenditure: 5315000 USD · 2010-10-01 – 2011-06-30 Source

Free cash flow

-56.4 million USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Operating cash flow: 3696000 USD · 2010-10-01 – 2010-12-31 Source
Operating cash flow: -44918000 USD · 2011-01-01 – 2011-03-31 Source
Operating cash flow: -63575000 USD · 2010-10-01 – 2011-06-30 Source
Operating cash flow: -41222000 USD · 2010-10-01 – 2011-03-31 Source
Operating cash flow: -49010000 USD · 2010-10-01 – 2011-09-30 Source
Operating cash flow: -63575000 USD · 2010-10-01 – 2011-06-30 Source
Capital expenditure: 1135000 USD · 2010-10-01 – 2010-12-31 Source
Capital expenditure: 2371000 USD · 2011-01-01 – 2011-03-31 Source
Capital expenditure: 5315000 USD · 2010-10-01 – 2011-06-30 Source
Capital expenditure: 3506000 USD · 2010-10-01 – 2011-03-31 Source
Capital expenditure: 7408000 USD · 2010-10-01 – 2011-09-30 Source
Capital expenditure: 5315000 USD · 2010-10-01 – 2011-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2012-04-27.

Financial data available through: 2011-09-30.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2011-09-30
Operating income: 3 of 11 periods available· newest 2011-09-30
Net income: 10 of 11 periods available· newest 2011-09-30
Operating cash flow: 10 of 11 periods available· newest 2011-09-30
Capital expenditure: 10 of 11 periods available· newest 2011-09-30
Total assets: 3 of 11 periods available· newest 2011-09-30
Total liabilities: 3 of 11 periods available· newest 2011-09-30
Current assets: 3 of 11 periods available· newest 2011-09-30
Current liabilities: 3 of 11 periods available· newest 2011-09-30
Cash and cash equivalents: 3 of 11 periods available· newest 2011-09-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+32.7%

Prior period

USD 354.59 million

2009-10-01 – 2010-09-30
Current period

USD 470.38 million

2010-10-01 – 2011-09-30

Exact inputs and evidence

470384000 − 354587000 = 115797000 USD

354587000 USD · 2009-10-01 – 2010-09-30
Inspect prior input Prior source
470384000 USD · 2010-10-01 – 2011-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Aptalis Pharma Inc · 2011-09-30 Aptalis Pharma Inc (edgar:1444570) Year-over-year change in Revenue: 115797000 USD Concept: fundies:Revenue Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 470384000 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#14571 Input fundies:Revenue: 354587000 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#14571
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 17.52 million

Prior period

−USD 170.37 million

2009-10-01 – 2010-09-30
Current period

−USD 187.88 million

2010-10-01 – 2011-09-30

Exact inputs and evidence

-187884000 − -170366000 = -17518000 USD

-170366000 USD · 2009-10-01 – 2010-09-30
Inspect prior input Prior source
-187884000 USD · 2010-10-01 – 2011-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Aptalis Pharma Inc · 2011-09-30 Aptalis Pharma Inc (edgar:1444570) Year-over-year change in Net income: -17518000 USD Concept: fundies:NetIncome Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -187884000 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17047 Input fundies:NetIncome: -170366000 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17047
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-177.6%

Prior period

USD 63.12 million

2009-10-01 – 2010-09-30
Current period

−USD 49.01 million

2010-10-01 – 2011-09-30

Exact inputs and evidence

-49010000 − 63120000 = -112130000 USD

63120000 USD · 2009-10-01 – 2010-09-30
Inspect prior input Prior source
-49010000 USD · 2010-10-01 – 2011-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Aptalis Pharma Inc · 2011-09-30 Aptalis Pharma Inc (edgar:1444570) Year-over-year change in Operating cash flow: -112130000 USD Concept: fundies:OperatingCashFlow Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -49010000 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17355 Input fundies:OperatingCashFlow: 63120000 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17355
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+22.3%

Prior period

USD 6.06 million

2009-10-01 – 2010-09-30
Current period

USD 7.41 million

2010-10-01 – 2011-09-30

Exact inputs and evidence

7408000 − 6058000 = 1350000 USD

6058000 USD · 2009-10-01 – 2010-09-30
Inspect prior input Prior source
7408000 USD · 2010-10-01 – 2011-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Aptalis Pharma Inc · 2011-09-30 Aptalis Pharma Inc (edgar:1444570) Year-over-year change in Capital expenditure: 1350000 USD Concept: fundies:CapitalExpenditure Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 7408000 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17439 Input fundies:CapitalExpenditure: 6058000 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17439
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2011 2010-10-01 – 2011-09-30

Revenue USD 470.38 million 100% of revenue
Operating costs Derived USD 536.79 million 114% of revenue
Operating income −USD 66.4 million −14% of revenue
Tax, interest and other Derived USD 121.48 million 26% of revenue
Net income −USD 187.88 million −40% of revenue

Cash

Operating cash flow −USD 49.01 million −10% of revenue
Capital expenditure USD 7.41 million 1.6% of revenue
Free cash flow Derived −USD 56.42 million −12% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2009 Net loss: net income was −1.9% of revenue.
2010 Operating loss: operating costs were 129% of revenue.
2011 Operating loss: operating costs were 114% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2009 2008-10-01 – 2009-09-30	416939000	383323000 Derived	33616000	41510000 Derived	-7894000	81792000 Derived	Source 2008-10-01 – 2009-09-30: 416939000 USD Inspect Revenue Open source 2008-10-01 – 2009-09-30: 33616000 USD Inspect Operating Income Open source 2008-10-01 – 2009-09-30: -7894000 USD Inspect Net Income Open source 2008-10-01 – 2009-09-30: 92382000 USD Inspect Operating Cash Flow Open source 2008-10-01 – 2009-09-30: 10590000 USD Inspect Capital Expenditure Open source
2010 2009-10-01 – 2010-09-30	354587000	458192000 Derived	-103605000	66761000 Derived	-170366000	57062000 Derived	Source 2009-10-01 – 2010-09-30: 354587000 USD Inspect Revenue Open source 2009-10-01 – 2010-09-30: -103605000 USD Inspect Operating Income Open source 2009-10-01 – 2010-09-30: -170366000 USD Inspect Net Income Open source 2009-10-01 – 2010-09-30: 63120000 USD Inspect Operating Cash Flow Open source 2009-10-01 – 2010-09-30: 6058000 USD Inspect Capital Expenditure Open source
2011 2010-10-01 – 2011-09-30	470384000	536786000 Derived	-66402000	121482000 Derived	-187884000	-56418000 Derived	Source 2010-10-01 – 2011-09-30: 470384000 USD Inspect Revenue Open source 2010-10-01 – 2011-09-30: -66402000 USD Inspect Operating Income Open source 2010-10-01 – 2011-09-30: -187884000 USD Inspect Net Income Open source 2010-10-01 – 2011-09-30: -49010000 USD Inspect Operating Cash Flow Open source 2010-10-01 – 2011-09-30: 7408000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 470.4M 2011

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-09-30	Revenue	416939000	Revenue: 416939000 Open source
20102010-09-30	Revenue	354587000	Revenue: 354587000 Open source
20112011-09-30	Revenue	470384000	Revenue: 470384000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

32.7% 2011

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20092009-09-30	Year over year	No prior comparable period	Revenue: 416939000 Open source
20102010-09-30	Year over year	-15%	Revenue: 354587000 Open source Revenue: 416939000 Open source
20112011-09-30	Year over year	32.7%	Revenue: 470384000 Open source Revenue: 354587000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -14.1% 2011

Net margin -39.9% 2011

Free cash flow margin -12% 2011

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20092009-09-30	Operating margin	8.1%	Operating Income: 33616000 Open source Revenue: 416939000 Open source
20102010-09-30	Operating margin	-29.2%	Operating Income: -103605000 Open source Revenue: 354587000 Open source
20112011-09-30	Operating margin	-14.1%	Operating Income: -66402000 Open source Revenue: 470384000 Open source
20092009-09-30	Net margin	-1.9%	Net Income: -7894000 Open source Revenue: 416939000 Open source
20102010-09-30	Net margin	-48%	Net Income: -170366000 Open source Revenue: 354587000 Open source
20112011-09-30	Net margin	-39.9%	Net Income: -187884000 Open source Revenue: 470384000 Open source
20092009-09-30	Free cash flow margin	19.6%	Revenue: 416939000 Open source Operating Cash Flow: 92382000 Open source Capital Expenditure: 10590000 Open source
20102010-09-30	Free cash flow margin	16.1%	Revenue: 354587000 Open source Operating Cash Flow: 63120000 Open source Capital Expenditure: 6058000 Open source
20112011-09-30	Free cash flow margin	-12%	Revenue: 470384000 Open source Operating Cash Flow: -49010000 Open source Capital Expenditure: 7408000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -49M 2011

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-09-30	Operating cash flow	92382000	Operating Cash Flow: 92382000 Open source
20102010-09-30	Operating cash flow	63120000	Operating Cash Flow: 63120000 Open source
20112011-09-30	Operating cash flow	-49010000	Operating Cash Flow: -49010000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -56.4M 2011

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-09-30	Free cash flow	81792000	Operating Cash Flow: 92382000 Open source Capital Expenditure: 10590000 Open source
20102010-09-30	Free cash flow	57062000	Operating Cash Flow: 63120000 Open source Capital Expenditure: 6058000 Open source
20112011-09-30	Free cash flow	-56418000	Operating Cash Flow: -49010000 Open source Capital Expenditure: 7408000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

102.2% 2011

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20092009-09-30	Liabilities / assets	82.1%	Total Liabilities: 750838000 Open source Total Assets: 914602000 Open source
20102010-09-30	Liabilities / assets	102.9%	Total Liabilities: 734209000 Open source Total Assets: 713177000 Open source
20112011-09-30	Liabilities / assets	102.2%	Total Liabilities: 1285234000 Open source Total Assets: 1257860000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.53× 2011

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20092009-09-30	Current assets / current liabilities	2.07×	Current Assets: 250682000 Open source Current Liabilities: 121022000 Open source
20102010-09-30	Current assets / current liabilities	2.04×	Current Assets: 226749000 Open source Current Liabilities: 111329000 Open source
20112011-09-30	Current assets / current liabilities	1.53×	Current Assets: 272321000 Open source Current Liabilities: 177654000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2006 2005-10-01 – 2006-09-30	USD 39.12 million Exact value Exact value: 39119000 USD 2005-10-01 – 2006-09-30: 39119000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Aptalis Pharma Inc · 2006-09-30 Aptalis Pharma Inc (edgar:1444570) Net Income: 39119000 USD Concept: fundies:NetIncome Period: 2005-10-01 to 2006-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3ANetIncome&period=2006-09-30&surface=latest&period_type=duration&start=2005-10-01&unit=USD&dimensions= Input fundies:NetIncome: 39119000 USD (2005-10-01 to 2006-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-08-258292.txt#12033 The citation records this snapshot. The page link may show a newer release later.	USD 84.33 million Exact value Exact value: 84334000 USD 2005-10-01 – 2006-09-30: 84334000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aptalis Pharma Inc · 2006-09-30 Aptalis Pharma Inc (edgar:1444570) Operating Cash Flow: 84334000 USD Concept: fundies:OperatingCashFlow Period: 2005-10-01 to 2006-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3AOperatingCashFlow&period=2006-09-30&surface=latest&period_type=duration&start=2005-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 84334000 USD (2005-10-01 to 2006-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-08-258292.txt#12257 The citation records this snapshot. The page link may show a newer release later.	USD 4.04 million Exact value Exact value: 4038000 USD 2005-10-01 – 2006-09-30: 4038000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aptalis Pharma Inc · 2006-09-30 Aptalis Pharma Inc (edgar:1444570) Capital Expenditure: 4038000 USD Concept: fundies:CapitalExpenditure Period: 2005-10-01 to 2006-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3ACapitalExpenditure&period=2006-09-30&surface=latest&period_type=duration&start=2005-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4038000 USD (2005-10-01 to 2006-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-08-258292.txt#12353 The citation records this snapshot. The page link may show a newer release later.	USD 80.3 million Calculation and evidence 84334000 − 4038000 USD Exact free cash flow: 80296000 USD 2005-10-01 – 2006-09-30: 84334000 USD · Inspect Operating Cash Flow · Source 2005-10-01 – 2006-09-30: 4038000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aptalis Pharma Inc · 2006-09-30 Aptalis Pharma Inc (edgar:1444570) Free cash flow: 80296000 USD Concept: free-cash-flow Period: 2005-10-01 to 2006-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 84334000 USD (2005-10-01 to 2006-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-08-258292.txt#12257 Input fundies:CapitalExpenditure: 4038000 USD (2005-10-01 to 2006-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-08-258292.txt#12353 The citation records this snapshot. The page link may show a newer release later.
2007 2006-10-01 – 2007-09-30	USD 71.47 million Exact value Exact value: 71465000 USD 2006-10-01 – 2007-09-30: 71465000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Aptalis Pharma Inc · 2007-09-30 Aptalis Pharma Inc (edgar:1444570) Net Income: 71465000 USD Concept: fundies:NetIncome Period: 2006-10-01 to 2007-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3ANetIncome&period=2007-09-30&surface=latest&period_type=duration&start=2006-10-01&unit=USD&dimensions= Input fundies:NetIncome: 71465000 USD (2006-10-01 to 2007-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001199073-09-001017.txt#22624 The citation records this snapshot. The page link may show a newer release later.	USD 136.1 million Exact value Exact value: 136102000 USD 2006-10-01 – 2007-09-30: 136102000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aptalis Pharma Inc · 2007-09-30 Aptalis Pharma Inc (edgar:1444570) Operating Cash Flow: 136102000 USD Concept: fundies:OperatingCashFlow Period: 2006-10-01 to 2007-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3AOperatingCashFlow&period=2007-09-30&surface=latest&period_type=duration&start=2006-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 136102000 USD (2006-10-01 to 2007-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001199073-09-001017.txt#22911 The citation records this snapshot. The page link may show a newer release later.	USD 6.79 million Exact value Exact value: 6789000 USD 2006-10-01 – 2007-09-30: 6789000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aptalis Pharma Inc · 2007-09-30 Aptalis Pharma Inc (edgar:1444570) Capital Expenditure: 6789000 USD Concept: fundies:CapitalExpenditure Period: 2006-10-01 to 2007-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3ACapitalExpenditure&period=2007-09-30&surface=latest&period_type=duration&start=2006-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6789000 USD (2006-10-01 to 2007-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001199073-09-001017.txt#22999 The citation records this snapshot. The page link may show a newer release later.	USD 129.31 million Calculation and evidence 136102000 − 6789000 USD Exact free cash flow: 129313000 USD 2006-10-01 – 2007-09-30: 136102000 USD · Inspect Operating Cash Flow · Source 2006-10-01 – 2007-09-30: 6789000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aptalis Pharma Inc · 2007-09-30 Aptalis Pharma Inc (edgar:1444570) Free cash flow: 129313000 USD Concept: free-cash-flow Period: 2006-10-01 to 2007-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 136102000 USD (2006-10-01 to 2007-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001199073-09-001017.txt#22911 Input fundies:CapitalExpenditure: 6789000 USD (2006-10-01 to 2007-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001199073-09-001017.txt#22999 The citation records this snapshot. The page link may show a newer release later.
2008 2007-02-26 – 2008-02-25	USD 17.13 million Exact value Exact value: 17125000 USD 2007-02-26 – 2008-02-25: 17125000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Aptalis Pharma Inc · 2008-02-25 Aptalis Pharma Inc (edgar:1444570) Net Income: 17125000 USD Concept: fundies:NetIncome Period: 2007-02-26 to 2008-02-25 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3ANetIncome&period=2008-02-25&surface=latest&period_type=duration&start=2007-02-26&unit=USD&dimensions= Input fundies:NetIncome: 17125000 USD (2007-02-26 to 2008-02-25) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001199073-09-001017.txt#22624 The citation records this snapshot. The page link may show a newer release later.	USD 73.25 million Exact value Exact value: 73245000 USD 2007-02-26 – 2008-02-25: 73245000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aptalis Pharma Inc · 2008-02-25 Aptalis Pharma Inc (edgar:1444570) Operating Cash Flow: 73245000 USD Concept: fundies:OperatingCashFlow Period: 2007-02-26 to 2008-02-25 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3AOperatingCashFlow&period=2008-02-25&surface=latest&period_type=duration&start=2007-02-26&unit=USD&dimensions= Input fundies:OperatingCashFlow: 73245000 USD (2007-02-26 to 2008-02-25) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001199073-09-001017.txt#22911 The citation records this snapshot. The page link may show a newer release later.	USD 3.31 million Exact value Exact value: 3314000 USD 2007-02-26 – 2008-02-25: 3314000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aptalis Pharma Inc · 2008-02-25 Aptalis Pharma Inc (edgar:1444570) Capital Expenditure: 3314000 USD Concept: fundies:CapitalExpenditure Period: 2007-02-26 to 2008-02-25 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3ACapitalExpenditure&period=2008-02-25&surface=latest&period_type=duration&start=2007-02-26&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3314000 USD (2007-02-26 to 2008-02-25) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001199073-09-001017.txt#22999 The citation records this snapshot. The page link may show a newer release later.	USD 69.93 million Calculation and evidence 73245000 − 3314000 USD Exact free cash flow: 69931000 USD 2007-02-26 – 2008-02-25: 73245000 USD · Inspect Operating Cash Flow · Source 2007-02-26 – 2008-02-25: 3314000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aptalis Pharma Inc · 2008-02-25 Aptalis Pharma Inc (edgar:1444570) Free cash flow: 69931000 USD Concept: free-cash-flow Period: 2007-02-26 to 2008-02-25 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 73245000 USD (2007-02-26 to 2008-02-25) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001199073-09-001017.txt#22911 Input fundies:CapitalExpenditure: 3314000 USD (2007-02-26 to 2008-02-25) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001199073-09-001017.txt#22999 The citation records this snapshot. The page link may show a newer release later.
2008 2007-10-01 – 2008-09-30	−USD 289.26 million Exact value Exact value: -289264000 USD 2007-10-01 – 2008-09-30: -289264000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Aptalis Pharma Inc · 2008-09-30 Aptalis Pharma Inc (edgar:1444570) Net Income: -289264000 USD Concept: fundies:NetIncome Period: 2007-10-01 to 2008-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3ANetIncome&period=2008-09-30&surface=latest&period_type=duration&start=2007-10-01&unit=USD&dimensions= Input fundies:NetIncome: -289264000 USD (2007-10-01 to 2008-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001199073-09-001017.txt#22624 The citation records this snapshot. The page link may show a newer release later.	−USD 47.51 million Exact value Exact value: -47512000 USD 2007-10-01 – 2008-09-30: -47512000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aptalis Pharma Inc · 2008-09-30 Aptalis Pharma Inc (edgar:1444570) Operating Cash Flow: -47512000 USD Concept: fundies:OperatingCashFlow Period: 2007-10-01 to 2008-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3AOperatingCashFlow&period=2008-09-30&surface=latest&period_type=duration&start=2007-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -47512000 USD (2007-10-01 to 2008-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001199073-09-001017.txt#22911 The citation records this snapshot. The page link may show a newer release later.	USD 3.06 million Exact value Exact value: 3061000 USD 2007-10-01 – 2008-09-30: 3061000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aptalis Pharma Inc · 2008-09-30 Aptalis Pharma Inc (edgar:1444570) Capital Expenditure: 3061000 USD Concept: fundies:CapitalExpenditure Period: 2007-10-01 to 2008-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3ACapitalExpenditure&period=2008-09-30&surface=latest&period_type=duration&start=2007-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3061000 USD (2007-10-01 to 2008-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001199073-09-001017.txt#22999 The citation records this snapshot. The page link may show a newer release later.	−USD 50.57 million Calculation and evidence -47512000 − 3061000 USD Exact free cash flow: -50573000 USD 2007-10-01 – 2008-09-30: -47512000 USD · Inspect Operating Cash Flow · Source 2007-10-01 – 2008-09-30: 3061000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aptalis Pharma Inc · 2008-09-30 Aptalis Pharma Inc (edgar:1444570) Free cash flow: -50573000 USD Concept: free-cash-flow Period: 2007-10-01 to 2008-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -47512000 USD (2007-10-01 to 2008-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001199073-09-001017.txt#22911 Input fundies:CapitalExpenditure: 3061000 USD (2007-10-01 to 2008-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001199073-09-001017.txt#22999 The citation records this snapshot. The page link may show a newer release later.
2008 2007-12-17 – 2008-12-16	−USD 289.26 million Exact value Exact value: -289264000 USD 2007-12-17 – 2008-12-16: -289264000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Aptalis Pharma Inc · 2008-12-16 Aptalis Pharma Inc (edgar:1444570) Net Income: -289264000 USD Concept: fundies:NetIncome Period: 2007-12-17 to 2008-12-16 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3ANetIncome&period=2008-12-16&surface=latest&period_type=duration&start=2007-12-17&unit=USD&dimensions= Input fundies:NetIncome: -289264000 USD (2007-12-17 to 2008-12-16) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0000950123-10-114353.txt#21385 The citation records this snapshot. The page link may show a newer release later.	−USD 47.51 million Exact value Exact value: -47512000 USD 2007-12-17 – 2008-12-16: -47512000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aptalis Pharma Inc · 2008-12-16 Aptalis Pharma Inc (edgar:1444570) Operating Cash Flow: -47512000 USD Concept: fundies:OperatingCashFlow Period: 2007-12-17 to 2008-12-16 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-16&surface=latest&period_type=duration&start=2007-12-17&unit=USD&dimensions= Input fundies:OperatingCashFlow: -47512000 USD (2007-12-17 to 2008-12-16) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0000950123-10-114353.txt#21788 The citation records this snapshot. The page link may show a newer release later.	USD 3.06 million Exact value Exact value: 3061000 USD 2007-12-17 – 2008-12-16: 3061000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aptalis Pharma Inc · 2008-12-16 Aptalis Pharma Inc (edgar:1444570) Capital Expenditure: 3061000 USD Concept: fundies:CapitalExpenditure Period: 2007-12-17 to 2008-12-16 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-16&surface=latest&period_type=duration&start=2007-12-17&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3061000 USD (2007-12-17 to 2008-12-16) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0000950123-10-114353.txt#21851 The citation records this snapshot. The page link may show a newer release later.	−USD 50.57 million Calculation and evidence -47512000 − 3061000 USD Exact free cash flow: -50573000 USD 2007-12-17 – 2008-12-16: -47512000 USD · Inspect Operating Cash Flow · Source 2007-12-17 – 2008-12-16: 3061000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aptalis Pharma Inc · 2008-12-16 Aptalis Pharma Inc (edgar:1444570) Free cash flow: -50573000 USD Concept: free-cash-flow Period: 2007-12-17 to 2008-12-16 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -47512000 USD (2007-12-17 to 2008-12-16) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0000950123-10-114353.txt#21788 Input fundies:CapitalExpenditure: 3061000 USD (2007-12-17 to 2008-12-16) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0000950123-10-114353.txt#21851 The citation records this snapshot. The page link may show a newer release later.
2009 2008-10-01 – 2009-09-30	−USD 7.89 million Exact value Exact value: -7894000 USD 2008-10-01 – 2009-09-30: -7894000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Aptalis Pharma Inc · 2009-09-30 Aptalis Pharma Inc (edgar:1444570) Net Income: -7894000 USD Concept: fundies:NetIncome Period: 2008-10-01 to 2009-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3ANetIncome&period=2009-09-30&surface=latest&period_type=duration&start=2008-10-01&unit=USD&dimensions= Input fundies:NetIncome: -7894000 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17047 The citation records this snapshot. The page link may show a newer release later.	USD 92.38 million Exact value Exact value: 92382000 USD 2008-10-01 – 2009-09-30: 92382000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aptalis Pharma Inc · 2009-09-30 Aptalis Pharma Inc (edgar:1444570) Operating Cash Flow: 92382000 USD Concept: fundies:OperatingCashFlow Period: 2008-10-01 to 2009-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3AOperatingCashFlow&period=2009-09-30&surface=latest&period_type=duration&start=2008-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 92382000 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17355 The citation records this snapshot. The page link may show a newer release later.	USD 10.59 million Exact value Exact value: 10590000 USD 2008-10-01 – 2009-09-30: 10590000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aptalis Pharma Inc · 2009-09-30 Aptalis Pharma Inc (edgar:1444570) Capital Expenditure: 10590000 USD Concept: fundies:CapitalExpenditure Period: 2008-10-01 to 2009-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3ACapitalExpenditure&period=2009-09-30&surface=latest&period_type=duration&start=2008-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10590000 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17439 The citation records this snapshot. The page link may show a newer release later.	USD 81.79 million Calculation and evidence 92382000 − 10590000 USD Exact free cash flow: 81792000 USD 2008-10-01 – 2009-09-30: 92382000 USD · Inspect Operating Cash Flow · Source 2008-10-01 – 2009-09-30: 10590000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aptalis Pharma Inc · 2009-09-30 Aptalis Pharma Inc (edgar:1444570) Free cash flow: 81792000 USD Concept: free-cash-flow Period: 2008-10-01 to 2009-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 92382000 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17355 Input fundies:CapitalExpenditure: 10590000 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17439 The citation records this snapshot. The page link may show a newer release later.
2009 2008-12-17 – 2009-12-16	−USD 7.89 million Exact value Exact value: -7894000 USD 2008-12-17 – 2009-12-16: -7894000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Aptalis Pharma Inc · 2009-12-16 Aptalis Pharma Inc (edgar:1444570) Net Income: -7894000 USD Concept: fundies:NetIncome Period: 2008-12-17 to 2009-12-16 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3ANetIncome&period=2009-12-16&surface=latest&period_type=duration&start=2008-12-17&unit=USD&dimensions= Input fundies:NetIncome: -7894000 USD (2008-12-17 to 2009-12-16) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0000950123-10-114353.txt#21385 The citation records this snapshot. The page link may show a newer release later.	USD 92.38 million Exact value Exact value: 92382000 USD 2008-12-17 – 2009-12-16: 92382000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aptalis Pharma Inc · 2009-12-16 Aptalis Pharma Inc (edgar:1444570) Operating Cash Flow: 92382000 USD Concept: fundies:OperatingCashFlow Period: 2008-12-17 to 2009-12-16 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-16&surface=latest&period_type=duration&start=2008-12-17&unit=USD&dimensions= Input fundies:OperatingCashFlow: 92382000 USD (2008-12-17 to 2009-12-16) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0000950123-10-114353.txt#21788 The citation records this snapshot. The page link may show a newer release later.	USD 10.59 million Exact value Exact value: 10590000 USD 2008-12-17 – 2009-12-16: 10590000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aptalis Pharma Inc · 2009-12-16 Aptalis Pharma Inc (edgar:1444570) Capital Expenditure: 10590000 USD Concept: fundies:CapitalExpenditure Period: 2008-12-17 to 2009-12-16 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-16&surface=latest&period_type=duration&start=2008-12-17&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10590000 USD (2008-12-17 to 2009-12-16) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0000950123-10-114353.txt#21851 The citation records this snapshot. The page link may show a newer release later.	USD 81.79 million Calculation and evidence 92382000 − 10590000 USD Exact free cash flow: 81792000 USD 2008-12-17 – 2009-12-16: 92382000 USD · Inspect Operating Cash Flow · Source 2008-12-17 – 2009-12-16: 10590000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aptalis Pharma Inc · 2009-12-16 Aptalis Pharma Inc (edgar:1444570) Free cash flow: 81792000 USD Concept: free-cash-flow Period: 2008-12-17 to 2009-12-16 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 92382000 USD (2008-12-17 to 2009-12-16) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0000950123-10-114353.txt#21788 Input fundies:CapitalExpenditure: 10590000 USD (2008-12-17 to 2009-12-16) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0000950123-10-114353.txt#21851 The citation records this snapshot. The page link may show a newer release later.
2010 2009-10-01 – 2010-09-30	−USD 170.37 million Exact value Exact value: -170366000 USD 2009-10-01 – 2010-09-30: -170366000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Aptalis Pharma Inc · 2010-09-30 Aptalis Pharma Inc (edgar:1444570) Net Income: -170366000 USD Concept: fundies:NetIncome Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3ANetIncome&period=2010-09-30&surface=latest&period_type=duration&start=2009-10-01&unit=USD&dimensions= Input fundies:NetIncome: -170366000 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17047 The citation records this snapshot. The page link may show a newer release later.	USD 63.12 million Exact value Exact value: 63120000 USD 2009-10-01 – 2010-09-30: 63120000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aptalis Pharma Inc · 2010-09-30 Aptalis Pharma Inc (edgar:1444570) Operating Cash Flow: 63120000 USD Concept: fundies:OperatingCashFlow Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3AOperatingCashFlow&period=2010-09-30&surface=latest&period_type=duration&start=2009-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 63120000 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17355 The citation records this snapshot. The page link may show a newer release later.	USD 6.06 million Exact value Exact value: 6058000 USD 2009-10-01 – 2010-09-30: 6058000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aptalis Pharma Inc · 2010-09-30 Aptalis Pharma Inc (edgar:1444570) Capital Expenditure: 6058000 USD Concept: fundies:CapitalExpenditure Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3ACapitalExpenditure&period=2010-09-30&surface=latest&period_type=duration&start=2009-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6058000 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17439 The citation records this snapshot. The page link may show a newer release later.	USD 57.06 million Calculation and evidence 63120000 − 6058000 USD Exact free cash flow: 57062000 USD 2009-10-01 – 2010-09-30: 63120000 USD · Inspect Operating Cash Flow · Source 2009-10-01 – 2010-09-30: 6058000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aptalis Pharma Inc · 2010-09-30 Aptalis Pharma Inc (edgar:1444570) Free cash flow: 57062000 USD Concept: free-cash-flow Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 63120000 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17355 Input fundies:CapitalExpenditure: 6058000 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17439 The citation records this snapshot. The page link may show a newer release later.
2010 2009-12-17 – 2010-12-16	−USD 170.37 million Exact value Exact value: -170366000 USD 2009-12-17 – 2010-12-16: -170366000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Aptalis Pharma Inc · 2010-12-16 Aptalis Pharma Inc (edgar:1444570) Net Income: -170366000 USD Concept: fundies:NetIncome Period: 2009-12-17 to 2010-12-16 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3ANetIncome&period=2010-12-16&surface=latest&period_type=duration&start=2009-12-17&unit=USD&dimensions= Input fundies:NetIncome: -170366000 USD (2009-12-17 to 2010-12-16) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0000950123-10-114353.txt#21385 The citation records this snapshot. The page link may show a newer release later.	USD 63.12 million Exact value Exact value: 63120000 USD 2009-12-17 – 2010-12-16: 63120000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aptalis Pharma Inc · 2010-12-16 Aptalis Pharma Inc (edgar:1444570) Operating Cash Flow: 63120000 USD Concept: fundies:OperatingCashFlow Period: 2009-12-17 to 2010-12-16 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-16&surface=latest&period_type=duration&start=2009-12-17&unit=USD&dimensions= Input fundies:OperatingCashFlow: 63120000 USD (2009-12-17 to 2010-12-16) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0000950123-10-114353.txt#21788 The citation records this snapshot. The page link may show a newer release later.	USD 6.06 million Exact value Exact value: 6058000 USD 2009-12-17 – 2010-12-16: 6058000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aptalis Pharma Inc · 2010-12-16 Aptalis Pharma Inc (edgar:1444570) Capital Expenditure: 6058000 USD Concept: fundies:CapitalExpenditure Period: 2009-12-17 to 2010-12-16 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-16&surface=latest&period_type=duration&start=2009-12-17&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6058000 USD (2009-12-17 to 2010-12-16) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0000950123-10-114353.txt#21851 The citation records this snapshot. The page link may show a newer release later.	USD 57.06 million Calculation and evidence 63120000 − 6058000 USD Exact free cash flow: 57062000 USD 2009-12-17 – 2010-12-16: 63120000 USD · Inspect Operating Cash Flow · Source 2009-12-17 – 2010-12-16: 6058000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aptalis Pharma Inc · 2010-12-16 Aptalis Pharma Inc (edgar:1444570) Free cash flow: 57062000 USD Concept: free-cash-flow Period: 2009-12-17 to 2010-12-16 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 63120000 USD (2009-12-17 to 2010-12-16) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0000950123-10-114353.txt#21788 Input fundies:CapitalExpenditure: 6058000 USD (2009-12-17 to 2010-12-16) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0000950123-10-114353.txt#21851 The citation records this snapshot. The page link may show a newer release later.
2011 2010-10-01 – 2011-09-30	−USD 187.88 million Exact value Exact value: -187884000 USD 2010-10-01 – 2011-09-30: -187884000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Aptalis Pharma Inc · 2011-09-30 Aptalis Pharma Inc (edgar:1444570) Net Income: -187884000 USD Concept: fundies:NetIncome Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3ANetIncome&period=2011-09-30&surface=latest&period_type=duration&start=2010-10-01&unit=USD&dimensions= Input fundies:NetIncome: -187884000 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17047 The citation records this snapshot. The page link may show a newer release later.	−USD 49.01 million Exact value Exact value: -49010000 USD 2010-10-01 – 2011-09-30: -49010000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aptalis Pharma Inc · 2011-09-30 Aptalis Pharma Inc (edgar:1444570) Operating Cash Flow: -49010000 USD Concept: fundies:OperatingCashFlow Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3AOperatingCashFlow&period=2011-09-30&surface=latest&period_type=duration&start=2010-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -49010000 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17355 The citation records this snapshot. The page link may show a newer release later.	USD 7.41 million Exact value Exact value: 7408000 USD 2010-10-01 – 2011-09-30: 7408000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Aptalis Pharma Inc · 2011-09-30 Aptalis Pharma Inc (edgar:1444570) Capital Expenditure: 7408000 USD Concept: fundies:CapitalExpenditure Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570/explain?concept=fundies%3ACapitalExpenditure&period=2011-09-30&surface=latest&period_type=duration&start=2010-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7408000 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17439 The citation records this snapshot. The page link may show a newer release later.	−USD 56.42 million Calculation and evidence -49010000 − 7408000 USD Exact free cash flow: -56418000 USD 2010-10-01 – 2011-09-30: -49010000 USD · Inspect Operating Cash Flow · Source 2010-10-01 – 2011-09-30: 7408000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Aptalis Pharma Inc · 2011-09-30 Aptalis Pharma Inc (edgar:1444570) Free cash flow: -56418000 USD Concept: free-cash-flow Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-05T00:59:36Z Snapshot: 492d4a7d5b035c03e0872ef8a574c2f0be8b2f238b651aa785aa782608291024 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1444570?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -49010000 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17355 Input fundies:CapitalExpenditure: 7408000 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1444570/0001193125-11-345928.txt#17439 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

15 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-05. Source filing dates and reporting periods are shown separately.

Identifiers: 0001444570, 1444570, edgar:1444570

Also known as Axcan Intermediate Holdings Inc.

Aptalis Pharma Inc

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2011 2010-10-01 – 2011-09-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation